Share

New combo jab OK'd for kids

accreditation
Pentacel, a combination vaccine for five childhood diseases that would reduce the number of shots given to infants, received the approval of a US Food and Drug Administration advisory panel on Thursday.

The vaccine, which protects against diphtheria, tetanus, polio, whooping cough and invasive Hib disease, is made by Sanofi-Aventis SA.

The 13 to 2 vote in favour of the vaccine was based on studies that showed that four doses of Pentacel protected children from these diseases. Currently, US health officials recommend 23 separate shots for infants. Pentacel would reduce that to 16 shots - about two fewer at every checkup, Bloomberg News reported.

The advisory committee said that Pentacel appeared to work at least as well as individual vaccines designed to protect against the five diseases. They also said that reducing the number of shots may help improve immunisation rates.

It's expected that the FDA will decide by March 9 whether to act on the advisory committees' recommendation and approve Pentacel, Bloomberg reported. While the FDA isn't required to follow its committees' advice, it usually does so.

Currently, the only five-component childhood vaccine available in the US is Pediarix, made by GlaxoSmithKline. – (HealthDayNews)

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE